Carla Panisello

5PUBLICATIONS
47CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 16, 2025
A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR T-cell therapy in B-cell acute lymphoblastic leukemia.

Aïda Falgàs, Rodrigo Lázaro-Gorines, Samanta Romina Zanetti

|Oct 08, 2024
NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid-lymphoid representation with limited graft-versus-host disease.

Carla Panisello, Rosario Aschero, Alba Martinez-Moreno

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

|Jun 08, 2023
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.

Nadia Mensali, Hakan Köksal, Sandy Joaquina

|Dec 29, 2022
Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.

Jara Palomero, Carla Panisello, Maria Lozano-Rabella

Pageof 1

Frequent Collaborators

2 joint publications

Talia Velasco-Hernandez

2 joint publications

Clara Bueno

2 joint publications

Aïda Falgàs

2 joint publications

Mercedes Guerrero-Murillo